ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Medical Director at Caribou Biosciences, Inc. - ApplyBlast

Medical Director

Caribou Biosciences, Inc.

1 month ago

Berkeley, California, United States

Hybrid

Full Time

Director

1 applicant

View Job Listing

Apply to 100+ jobs

About this role

Caribou Biosciences is seeking a Medical Director to lead the clinical development strategy and execution for multiple pre-clinical programs, including the design and management of clinical trials from Phase I through IV. This hands-on role involves overseeing clinical research teams, managing vendors, and ensuring compliance with regulatory standards while advancing cell therapy products. The position requires close collaboration with senior management, cross-functional teams, and external investigators to drive the company's pipeline forward.

Responsibilities

Lead clinical trial design, execution, and data interpretation for multiple programs
Develop clinical strategy and manage regulatory submissions including IND and BLA filings
Oversee clinical research teams, CROs, and vendor relationships to ensure trial safety

Skills

Qualifications

MD degree

About Caribou Biosciences, Inc.

cariboubio.com

Headquarters

Berkeley, California, United States

Company Size

51-200 employees

Founded

2012

View Profile

Caribou Biosciences is a clinical-stage biopharmaceutical company developing genome-edited allogeneic (off‑the‑shelf) cell therapies for serious human diseases. The company leverages a next‑generation CRISPR platform and its patented chRDNA (CRISPR hybrid RNA‑DNA) technology to enable precise, multiplex genome edits while preserving genomic integrity. Caribou is advancing off‑the‑shelf CAR‑T programs for hematologic malignancies and uses “armoring” strategies (e.g., checkpoint disruption and immune cloaking) to enhance therapeutic activity. Leadership includes co‑founder and Nobel laureate Jennifer Doudna, and the company is progressing a clinical pipeline while recruiting talent.